Your search history is turned on.
Date: May 6, 2011 Jurisdictions: All jurisdictions
GOODMANS-#5964505-v3-WEX_Pharmaceuticals_-_Notice_of_Change_in_Corporate_Structure_under_51-102.DOC NOTICE OF CHANGE IN CORPORATE STRUCTURE PURSUANT TO SECTION 4.9 OF NATIONAL INSTRUMENT 51-102 Item 1: Names of the Parties to the Transaction WEX Pharmaceuticals Inc. (the Corporation) and 7735308 Canada Limited. Item 2: Description of the Transaction Pursuant to a circu...
GOODMANS-#5957677-v3-Early_Warning_Report.DOC EARLY WARNING REPORT UNDER NATIONAL INSTRUMENT 62-103 The following information is filed pursuant to the provisions listed above under applicable securities legislation: (a) The name and address of the offeror: CK Life Sciences Intl., (Holdings) Inc. (CKLS) 2 Dai Fu Street Tai Po Industrial Estate Tai Po, Hong Kong (b) The de...
Date: May 5, 2011 Jurisdictions: All jurisdictions
Microsoft Word - GOODMANS-5959696-v1-Press_Release_-_WEX_Announces_Completion_of_Amalgamation.doc WEX ANNOUNCES COMPLETION OF AMALGAMATION Vancouver, British Columbia (May 5, 2011) Pharmagesic (Holdings) Inc. (Pharmagesic) and WEX Pharmaceuticals Inc. (TSX: WXI) (WEX) jointly announced today that the previously announced amalgamation (the Amalg...
Microsoft Word - DM_VAN-#8047725-v1-WEX_Report_of_Voting_Results_Special_Meeting_May_4__2011.DOC DM_VAN/255263-00048/8047725.1 WEX PHARMACEUTICALS INC. Report of Voting Results (Section 11.3 of National Instrument 51-102) In accordance with section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations, this report briefly describes the matt...
Date: May 3, 2011 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - Minority Court Action-May-doc.doc WEX PHARMACEUTICALS INC. Suite 1601 700 West Pender Street Vancouver, BC Canada V6C 1G8 Tel: (604) 683-8880 Toll Free: 1-800-722-7549 Fax: (604) 683-8868 NEWS RELEASE May 3, 2011 Toronto Stock Exchange Trading Symbol: WXI http://www.wexpharma.com E-mail: wex@w...
Date: April 28, 2011 Jurisdictions: All jurisdictions
GOODMANS-#5946272-v7-WEX_Amalgamation_Agreement.DOC AMALGAMATION AGREEMENT THIS AGREEMENT entered into this 1st day of April, 2011 BETWEEN: WEX PHARMACEUTICALS INC., a corporation amalgamated pursuant to the Canada Business Corporations Act (the Corporation) 7735308 CANADA LIMITED, a corporation incorporated pursuant to the Canada Business Corporations Act (Subco...
GOODMANS-#5958561-v3-Amendment_No__1_to_Amalgamation_Agreement_between_WEX_Pharmaceuticals_and_7735308_Canada_Limited.DOC AMENDMENT NO. 1 TO AMALGAMATION AGREEMENT THIS AGREEMENT entered into this 28th day of April 2011 BETWEEN: WEX PHARMACEUTICALS INC., a corporation amalgamated pursuant to the Canada Business Corporations Act (the Corporation) 7735308 CANADA LIMITED...
Date: April 12, 2011 Jurisdictions: All jurisdictions
Microsoft Word - GOODMANS-#5953079-v3-WEX_Special_Meeting_-_Letter_of_Transmittal.DOC Please read carefully the instructions and rules set forth below before completing this Letter of Transmittal. LETTER OF TRANSMITTAL FOR RESTRICTED VOTING SHARES OF WEX PHARMACEUTICALS INC. This Letter of Transmittal, properly completed and duly executed...
Date: April 11, 2011 Jurisdictions: All jurisdictions
Microsoft Word - Report - WEX - FMV @ 28-Feb-2011 FINAL.docx I WEX Pharmaceuticals Inc. Fair Market Value of WEX Pharmaceuticals Inc. Shares as at 28 February 2011 01 April 2011 Reliance Restricted A Member Practice of Ernst & Young Global In accordance with our statement of work dated 18 March 2011, Ernst ...